106 results match your criteria: "centre hospitalier regional universitaire de Brest[Affiliation]"
Cancer Med
August 2014
CNRS UMR 8126, Université Paris-Sud, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France; INSERM UMR 1078, Etablissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, SFR ScInBioS, Université de Bretagne Occidentale, Faculté de Médecine, 22 avenue Camille Desmoulins, 29200, Brest, France.
Age at diagnosis, stage, and MYCN amplification are the cornerstones of the risk-stratification score of neuroblastoma that enables defining patients at low- and high risk. Refinement of this stratification is needed to optimize standard treatment and to plan future clinical trials. We investigated whether two parental imprinted miRNAs (miR-487b and miR-516a-5p) may lead to a risk score with a better discrimination.
View Article and Find Full Text PDFJ Fr Ophtalmol
May 2014
Service d'ophtalmologie, centre hospitalier régional universitaire de Brest, 2, avenue Maréchal-Foch, 29200 Brest, France.
Introduction: Currently, the use of multifocal IOL's remains controversial for patients with high myopia, especially because of the risk of retinal complications and poor quality of vision. Our goal was to evaluate this retinal risk and clarify the benefits obtained in this population in terms of visual acuity.
Patients And Methods: Twenty-nine highly myopic patients (52 eyes with over 6 diopters of myopia) aged 40-69 years with early cataract by LOCSIII were selected for multifocal lens implantation, based on a healthy endothelium and retina as well as better visual acuity corrected to at least 0.
Bioinformatics
July 2014
Inserm, U946, Genetic variability and human diseases, Paris, 75010, Université Paris Sud, Kremlin-Bicêtre, 94270, Fondation Jean Dausset CEPH, Paris, 75010, Université Paris-Diderot, UMR 946, Institut Universitaire d'Hématologie, Paris, 75475, Inserm, U1078, Génétique, Génomique fonctionnelle et Biotechnologies, Brest, 29218 and Centre Hospitalier Régional Universitaire de Brest, Brest, 29200, France Inserm, U946, Genetic variability and human diseases, Paris, 75010, Université Paris Sud, Kremlin-Bicêtre, 94270, Fondation Jean Dausset CEPH, Paris, 75010, Université Paris-Diderot, UMR 946, Institut Universitaire d'Hématologie, Paris, 75475, Inserm, U1078, Génétique, Génomique fonctionnelle et Biotechnologies, Brest, 29218 and Centre Hospitalier Régional Universitaire de Brest, Brest, 29200, France.
Unlabelled: FSuite is a user-friendly pipeline developed for exploiting inbreeding information derived from human genomic data. It can make use of single nucleotide polymorphism chip or exome data. Compared with other software, the advantage of FSuite is that it provides a complete suite of scripts to describe and use the inbreeding information.
View Article and Find Full Text PDFPLoS One
January 2015
Institut National de la Santé Et de la Recherche Médicale, Unité Mixte de Recherche 1078, Université de Bretagne Occidentale, Structure Fédérative de Recherche ScInBioS, Faculté de Médecine, Brest, France ; Centre Hospitalier Régional Universitaire de Brest, Brest, France.
It is widely accepted that most colorectal cancers (CRCs) arise from colorectal adenomas (CRAs), but transcriptomic data characterizing the progression from colorectal normal mucosa to adenoma, and then to adenocarcinoma are scarce. These transition steps were investigated using microarrays, both at the level of gene expression and alternative pre-mRNA splicing. Many genes and exons were abnormally expressed in CRAs, even more than in CRCs, as compared to normal mucosae.
View Article and Find Full Text PDFSoc Psychiatry Psychiatr Epidemiol
January 2014
Secteur Hospitalo-Universitaire de Psychiatrie d'Adultes, Hôpital de Bohars, Centre Hospitalier Régional Universitaire de Brest, Route de Ploudalmézeau, 29820, Bohars, France,
Aims: Evaluating French general practitioners (GPs) diagnostic knowledge and practice in the detection and treatment of early schizophrenia as well as needs and preferences with specialist services.
Methods: A postal survey comprising 27 questions was conducted among 2,039 GPs from three counties of Western France. Composite scores were calculated to determine a level of diagnostic knowledge.
Br J Haematol
January 2012
Centre Hospitalier Régional Universitaire de Brest, Haematology Laboratory, Brest , France.
Bleeding risk is not predictable in patients with factor XI (FXI; F11) deficiency. In this prospective study, our objectives were to determine the biological determinants for bleeding risk in patients with heterozygous FXI deficiency. Patients were classified as either bleeding patients or non-bleeding patients by calculating the bleeding score (BS) described for von Willebrand disease.
View Article and Find Full Text PDF